API Pitavastatin Kalsyòm CAS 147526-32-7

Deskripsyon kout:

Pitavastatin yo itilize ansanm ak yon rejim apwopriye pou ede bese "move" kolestewòl ak grès (tankou LDL, trigliserid) ak ogmante "bon" kolestewòl (HDL) nan san an.

Kontakte: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

WhatsApp: +86 186 2503 6043 (WeChat & Telegram & Liy)

Skype: slhyzy

Voye imèl ba nou

Pwodwi detay

Tags pwodwi

Deskripsyon

Pitavastatin yo itilize ansanm ak yon rejim apwopriye pou ede bese "move" kolestewòl ak grès (tankou LDL, trigliserid) ak ogmante "bon" kolestewòl (HDL) nan san an.

Spesifikasyon:

Non pwodwi	Pitavastatin kalsyòm
Non Chimik	kalsyòm; (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
Lòt Non	PitavasttinCalcium;PitavastatinCalcium/NK-104;(+)-Monocalciunbis{(3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl-3-quinolyl]-3,5-dihydroxy-6-heptenotate };PitavastatincalciuM(Livalo);Kalsyòm(3R,5S,E)-7-(2-cyclopropyl-Chemicalbook4-(4-fluorophenyl)-quinolin-3-yl)-3,5-dihydroxyhept-6-enoate;(3R ,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoicacid,calciumsalt (2:1);NK-104Calcium;PitavastatinCalciuMDISCONTINUED
Nimewo CAS	147526-32-7
Fòmil molekilè	C25H26CaFNO4
Pwa fòmil	463,56
Aparans	Solid
Esè	98.0% min
Pake	20kg / sak / tanbou, 25kg / sak / tanbou, oswa jan ou mande yo
Depo	Sere veso a byen fèmen nan yon kote ki sèk ak fre.Pa ekspoze a limyè solèy la dirèk.
COA & MSDS	Disponib

Itilizasyon

Pitavastatin Kalsyòm se yon inibitè konpetitif nan anzim HMGCR (HMG-CoA reduktaz) rezilta nan yon rediksyon nan sentèz kolestewòl LDL.Etid altènatif montre ke pitavastatin ka siprime pwodiksyon oksijèn nan selil andotelyo pa anpeche NADPH oksidaz.Anplis de sa, pitavastatin diminye ekspresyon eNOS mRNA pandan y ap ogmante repons NO depandan ankouraje pa asetilkolin ak ionofò kalsyòm, A23187.Anplis de sa, pitavastatin inibit regilasyon an nan kanal potasyòm kalsyòm-aktive konduktivite pa bese nivo kolestewòl nan selil yo.